1) systematic therapy
全身用药
1.
In the control group, 34 cases had systematic therapy, and MTX (50mg) were injected through vei.
介入治疗组:34例,在B超引导下经穹窿穿刺入妊娠包块内,局部注射MTX50mg;对照组:34例,全身用药,MTX50mg静脉注射。
2) general anesthetics
全身麻醉药
1.
Research progress on receptor mechanisms of analgesia of general anesthetics;
全身麻醉药镇痛作用受体机制的研究进展
2.
Progress in the study of the effects of perioperative general anesthetics on cerebral hemodynamics
围术期常用全身麻醉药物对脑血流动力学影响的研究进展
3) general anesthetic
全身麻醉药
1.
Recently, our understanding has upgraded dramatically from unitary mechanism to complicated and mulriple mechanisms of action for general anesthetics, and the investigatation has developed from cell to molecular level.
关于各种类型的全身麻醉药如何产生全麻状态,尽管多年来的研究都已经在不同程度上揭示了一些可能的作用途径,但迄今都没有完全清楚阐述其作用机理。
4) Medication safety
用药安全
1.
Result: After utilizing the dispensation machine, working efficiency, medication safety as well as management of pharmacy and hospital were all improved.
目的:改变目前医院药房的发药模式,达到单剂量个体化给药,确保用药安全。
2.
Objectives: TO grasp the KAP status quo and related factors affecting the medical inpatients for their oral medication safety and Medical health care personnel to promote the inpatients for their oral medication safety that provide basis for education programs for promoting the inpatients for their oral medication safety and then do evaluation for the initial intervention program.
目的了解内科住院患者参与口服用药安全及医护人员促进其参与的认知、态度、行为(KAP)现状及相关影响因素,以为制定促进患者参与的用药安全教育方案提供依据。
5) safely use of medicine
用药安全
1.
The mechanisms of compound preparation of traditional Chinese medicine were systematically explained and the prevention measures of its adverse drug reactions(ADRs) were also introduced in this article, guaranteeing the qualitative stability of finished product, ensuring the safely use of medicine, and thus preventing and curing diseases.
系统阐述中药复方制剂在使用中不良反应产生的原因、经过及相应的防治措施,力争将其不良反应降至最低,从而达到成品稳定、用药安全、防病治病的目的。
补充资料：5FU联合用药方案
5FU联合用药方案
主要用于滋养细胞肿瘤晚期(ⅢB和Ⅳ期)病人，通常两药合用。5FU加KSM(更生霉素)或5FU加AT1258(消瘤芥)。联合用药时5FU用量减至每天每千克体重26mg左右，KSM用量为每天每千克体重6μg(一般每天用300μg)，分别溶于1000ml 5%葡萄糖溶液中，先滴5FU，完后用KSM。5FU加AT1258方案：AT1258 1次用量20～30mg，5FU每千克体重26mg，先静脉注射AT1258再滴5FU，两药合用8天为一疗程。间隔为3周。对耐药病人，如耐药原因是5FU用药量偏小，则常用5FU加KSM加AT1258三药联合应用，其剂量与二药联合方案相同。必要时三药方案与长春新碱合用，先用长春新碱1～2mg，再依次用AT1258，5FU和KSM，三药剂量不减，但疗程缩短至5～6天。疗程间隔为4周，依不良反应消退时间而定。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条